Replacement Director/PDMR Shareholding

RNS Number : 1378N
Dechra Pharmaceuticals PLC
03 September 2013
 





Replacement 

 

 

3 September 2013

 

Dechra® Pharmaceuticals PLC

("Dechra" or "the Company")

 

Director / PDMR shareholding

 

 

Dechra Pharmaceuticals PLC has been notified that on 3 September 2013 Ishbel Macpherson, Non-Executive Director, purchased 2,861 ordinary shares in the Company at a price of £6.935 each.  

 

Following this acquisition Ishbel Macpherson's beneficial interest in the Company is 5,848 shares (0.007% of current issued share capital).

 

 

 

For further information, please contact:

 

Zoe Goulding, Company Secretary            

Telephone number: 01606 814730

 

 

About Dechra

Dechra is an international specialist veterinary pharmaceuticals business.  Our expertise is in the development, manufacturing and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products.  For more information please visit: www.dechra.com

 

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSLLFSVATIVIIV
UK 100

Latest directors dealings